Herlax, V. S. (2024). Potential use of peptides mimicking CRAC/CARC domains as antivirulence therapies to inhibit RTX toxins activities. Web
Citación estilo ChicagoHerlax, Vanesa Silvana. Potential Use of Peptides Mimicking CRAC/CARC Domains As Antivirulence Therapies to Inhibit RTX Toxins Activities. 2024.
Cita MLAHerlax, Vanesa Silvana. Potential Use of Peptides Mimicking CRAC/CARC Domains As Antivirulence Therapies to Inhibit RTX Toxins Activities. 2024.
Precaución: Estas citas no son 100% exactas.